Track the Alzinova AB stock price and the full management transaction log of the company, a listed issuer based in Finland. Shares are quoted on FI FI, under the supervision of FIN-FSA. Operating in the Health Care sector, Alzinova AB has logged 0 insider filings. Market capitalisation: €135.6m. The full history is free.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
0 of 0 declarations
Alzinova AB is a Swedish biopharmaceutical company focused on developing treatments for Alzheimer's disease. It is listed on the Stockholm Stock Exchange (XSTO).